DE1387776U - - Google Patents
Info
- Publication number
- DE1387776U DE1387776U DENDAT1387776D DE1387776DU DE1387776U DE 1387776 U DE1387776 U DE 1387776U DE NDAT1387776 D DENDAT1387776 D DE NDAT1387776D DE 1387776D U DE1387776D U DE 1387776DU DE 1387776 U DE1387776 U DE 1387776U
- Authority
- DE
- Germany
- Prior art keywords
- office
- screw
- release
- documents8
- bodelles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Pens And Brushes (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1387776U true DE1387776U (OSRAM) |
Family
ID=699711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT1387776D Active DE1387776U (OSRAM) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE1387776U (OSRAM) |
-
0
- DE DENDAT1387776D patent/DE1387776U/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Asch et al. | The use of an impeded androgen—danazol—in the management of benign breast disorders | |
| Money et al. | The comparative effects of various steroids on lymphoid tissue of the rat | |
| DE1387776U (OSRAM) | ||
| Scott | Pathogenesis of bromodeoxyuridine‐induced polydactyly | |
| DE1376447U (OSRAM) | ||
| DE1385642U (OSRAM) | ||
| DE1378939U (OSRAM) | ||
| DE1423154U (OSRAM) | ||
| DE1369627U (OSRAM) | ||
| DE1372085U (OSRAM) | ||
| DE1365778U (OSRAM) | ||
| DE1413923U (OSRAM) | ||
| DE1441414U (OSRAM) | ||
| DE1383908U (OSRAM) | ||
| DE1404601U (OSRAM) | ||
| DE1429889U (OSRAM) | ||
| DE1431866U (OSRAM) | ||
| Menahan et al. | The effect of several lymphocytotoxic agents on murine leukemogenesis | |
| DE1373304U (OSRAM) | ||
| DE1365242U (OSRAM) | ||
| DE1377645U (OSRAM) | ||
| Dowsett et al. | Dose-related endocrine effects of pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients: Cancer Res.; 49/5 (1306–1312)/1989 | |
| DE1376472U (OSRAM) | ||
| DE1360124U (OSRAM) | ||
| DE1380197U (OSRAM) |